1996

NOVEMBER

Incorporated in Delaware under the name Advanced Medicine, Inc.

APRIL

Changed its name to Theravance, Inc.

2002
2002

NOVEMBER

Innoviva / GSK collaboration agreement signed

OCTOBER

Breo launched in the US

2013
2013

APRIL

Anoro launched in the US

JUNE

Spun-off research and development operations

2014
2016

JANUARY

Rebranded to Innoviva, Inc.

OCTOBER

Trelegy launched in the US.

2017
2020

JANUARY

Armata* and Innoviva announced strategic investment

JUNE

Entasis and Innoviva announced private placement

2020
2021

MAY

Innoviva announced strategic repurchase of GSK’s equity stake

MAY

 Announced acquisition of Entasis Therapeutics

2022
2022

JULY

Announced acquisition of La Jolla Pharmaceutical Company

JULY

Sold 15% stake in Theravance Respiratory Company**

2022
2023

MAY

Announced integration of Entasis and La Jolla into Innoviva Specialty Therapeutics

MAY

FDA approval of XACDURO®

2023